Przedstawiamy wybór publikacji naukowych związanych z immunoterapią IOZK. Możesz użyć filtrów, aby dokonać wyboru według typów nowotworów i metod lub wprowadzić wyszukiwane hasła.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002014-12-01 / Int J Hyperthermia 2014 Dec;30(8):531-9https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2014-12-01 / Int J Hyperthermia 2014 Dec;30(8):531-92014-12-01 00:00:002019-02-15 09:17:07Local tumour hyperthermia as immunotherapy for metastatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002014-11-27 / Cancer Res Treat 2015 Jul;47(3):518-26https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2014-11-27 / Cancer Res Treat 2015 Jul;47(3):518-262014-11-27 00:00:002019-02-15 08:46:10Improved Efficacy of a Dendritic Cell-Based Vaccine against a Murine Model of Colon Cancer: The Helper Protein Effect
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002014-11-07 / Eur. J. Immunol. 2014 Dec;44(12):3585-95https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2014-11-07 / Eur. J. Immunol. 2014 Dec;44(12):3585-952014-11-07 00:00:002019-02-15 08:45:48Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002014-11-01 / J. Exp. Clin. Cancer Res. 2014 Nov;33:91https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2014-11-01 / J. Exp. Clin. Cancer Res. 2014 Nov;33:912014-11-01 00:00:002014-11-01 00:00:00Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002014-10-29 / Rambam Maimonides Med J 2014 Oct;5(4):e0024https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2014-10-29 / Rambam Maimonides Med J 2014 Oct;5(4):e00242014-10-29 00:00:002019-02-15 08:39:37Dendritic cell cancer vaccines: from the bench to the bedside
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2014-10-24 17:16:162019-02-12 18:55:16IOZK Fallstudie über die erfolgreiche Behandlung eines metastasierten Prostatakarzinoms
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002014-10-21 / J. Cell. Mol. Med. 2015 Feb;19(2):340-50https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2014-10-21 / J. Cell. Mol. Med. 2015 Feb;19(2):340-502014-10-21 00:00:002014-10-21 00:00:00Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002014-10-15 / Mol Med Rep 2015 Jan;11(1):327-32https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2014-10-15 / Mol Med Rep 2015 Jan;11(1):327-322014-10-15 00:00:002019-02-15 09:18:18Inhibition of cell proliferation by mild hyperthermia at 43˚C with Paris Saponin I in the lung adenocarcinoma cell line PC-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002014-10-07 / Semin. Oncol. 2014 Dec;41(6):714-29https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2014-10-07 / Semin. Oncol. 2014 Dec;41(6):714-292014-10-07 00:00:002019-02-15 09:17:06Hyperthermia, radiation and chemotherapy: the role of heat in multidisciplinary cancer care
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002014-10-06 / Oncol Lett 2014 Dec;8(6):2403-2406https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2014-10-06 / Oncol Lett 2014 Dec;8(6):2403-24062014-10-06 00:00:002021-11-16 07:53:33Long-term remission of prostate cancer with extensive bone metastases upon immuno- and virotherapy: A case report
Dendritic cell-based vaccine research against cancer
Local tumour hyperthermia as immunotherapy for metastatic cancer
Prof. dr Schirrmacher publikuje e-book: Wykorzystanie odporności przeciwnowotworowej za pośrednictwem wirusów onkolitycznych
Improved Efficacy of a Dendritic Cell-Based Vaccine against a Murine Model of Colon Cancer: The Helper Protein Effect
CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses
Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model
Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment
Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancer
Perspectives for immunotherapy in glioblastoma treatment
Emerging treatment strategies for glioblastoma multiforme
Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm
Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression
Dendritic cell cancer vaccines: from the bench to the bedside
Studium przypadku IOZK dotyczące skutecznego leczenia raka prostaty z przerzutami
Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis
Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma
Inhibition of cell proliferation by mild hyperthermia at 43˚C with Paris Saponin I in the lung adenocarcinoma cell line PC-9
Apoptotic induction of lung adenocarcinoma A549 cells infected by recombinant RVG Newcastle disease virus (rL-RVG) in vitro
Hyperthermia, radiation and chemotherapy: the role of heat in multidisciplinary cancer care
Long-term remission of prostate cancer with extensive bone metastases upon immuno- and virotherapy: A case report